Protons against cancer: New research beamline for innovative radiotherapies

Prof. Dr Judith Reindl and PhD student Aikaterini Rousseti (from left to right) from the University of the Bundeswehr Munich present the experimental station for biological samples which is installed at the new Minibee beamline at HZB.

Prof. Dr Judith Reindl and PhD student Aikaterini Rousseti (from left to right) from the University of the Bundeswehr Munich present the experimental station for biological samples which is installed at the new Minibee beamline at HZB. © Kevin Fuchs / HZB

Magnetic quadrupoles focus the proton beam in front of the experiment platform.

Magnetic quadrupoles focus the proton beam in front of the experiment platform. © Kevin Fuchs / HZB

Together with the University of the Bundeswehr Munich, the HZB has set up a new beamline for preclinical research. It will enable experiments on biological samples on innovative radiation therapies with protons.

 

The proton accelerator at the Helmholtz-Zentrum Berlin (HZB) has been used for about 25 years to combat certain types of eye tumours. So far, over 4800 people have benefited from proton eye tumour therapy, which is carried out in collaboration with Charité – Universitätsmedizin Berlin.

Now, the proton accelerator at HZB also offers the option of conducting preclinical research: A mini-beamline for preclinical experiments (Minibee) has been set up for this purpose together with the University of the Bundeswehr in Munich. The HZB's Proton Therapy Department has built the beam guidance and control system for the minibeams. The University of the Bundeswehr in Munich, with Prof. Judith Reindl from the Institute of Applied Physics and Measurement Technology and the Section of Biomedical Radiation Physics, installed a platform for image-guided irradiation of biological samples. This will enable joint experiments on radiobiology and innovative radiation therapy in the future.

‘At Minibee, we can use medical research to investigate how changes in parameters and settings of the proton beam affect the treatment,’ says Judith Reindl. Among other things, Minibee is designed to generate ultrashort proton flashes (FLASH therapy) or needle-fine radiation (beamlets). ‘Our aim is to develop new methods that effectively destroy tumours while providing even better protection for healthy tissue,’ says Prof. Dr. Andrea Denker, head of the Department of Proton Therapy at HZB.

arö

  • Copy link

You might also be interested in

  • Catalysis research with the X-ray microscope at BESSY II
    Science Highlight
    27.03.2025
    Catalysis research with the X-ray microscope at BESSY II
    Contrary to what we learned at school, some catalysts do change during the reaction: for example, certain electrocatalysts can change their structure and composition during the reaction when an electric field is applied. The X-ray microscope TXM at BESSY II in Berlin is a unique tool for studying such changes in detail. The results help to develop innovative catalysts for a wide range of applications. One example was recently published in Nature Materials. It involved the synthesis of ammonia from waste nitrates.
  • BESSY II: Magnetic ‘microflowers’ enhance magnetic fields locally
    Science Highlight
    25.03.2025
    BESSY II: Magnetic ‘microflowers’ enhance magnetic fields locally
    A flower-shaped structure only a few micrometres in size made of a nickel-iron alloy can concentrate and locally enhance magnetic fields. The size of the effect can be controlled by varying the geometry and number of 'petals'. This magnetic metamaterial developed by Dr Anna Palau's group at the Institut de Ciencia de Materials de Barcelona (ICMAB) in collaboration with her partners of the CHIST-ERA MetaMagIC project, has now been studied at BESSY II in collaboration with Dr Sergio Valencia. Such a device can be used to increase the sensitivity of magnetic sensors, to reduce the energy required for creating local magnetic fields, but also, at the PEEM experimental station, to study samples under much higher magnetic fields than currently possible.
  • New material for efficient separation of Deuterium at elevated Temperatures
    Science Highlight
    19.03.2025
    New material for efficient separation of Deuterium at elevated Temperatures
    A novel porous material capable of separating deuterium (D2) from hydrogen (H2) at a temperature of 120 K has been introduced. Notably, this temperature exceeds the liquefaction point of natural gas, thus facilitating large-scale industrial applications. This advancement presents an attractive pathway for the economical production of D2 by leveraging the existing infrastructure of liquefied natural gas (LNG) production pipelines. The research conducted by Ulsan National Institute of Science & Technology (UNIST), Korea, Helmholtz-Zentrum Berlin, Heinz Maier Leibnitz Zentrum (MLZ), and Soongsil University, Korea, has been published in Nature Communications.